Works matching IS 00302414 AND DT 2009 AND VI 77 AND IP 2

Results: 10

Evaluating Quality in Clinical Cancer Research: The M.D. Anderson Cancer Center Experience.

Published in:

Oncology, 2009, v. 77, n. 2, p. 75, doi. 10.1159/000226772

By:

Cox, James D.;
Giralt, Sergio A.;
Veazie, Mary L.;
Ajani, Jaffer A.;
Bruner, Janet M.;
Ka Wah Chan;
Hittelman, Walter N.;
Hunt, Kelly K.;
Iyer, Revathy B.;
Karp, Daniel D.;
Kuban, Deborah A.;
Lippman, Scott M.;
Raad, Issam I.;
Rodriguez-Bigas, Miguel A.;
Zwelling, Leonard A.;
Markman, Maurie

Publication type:

Article

How Can Second-Line Therapy for Metastatic Renal Cell Carcinoma Help to Define an Overall Management Strategy?

Published in:

Oncology, 2009, v. 77, n. 2, p. 82, doi. 10.1159/000228835

By:

Melichar, Bohuslav

Publication type:

Article

Decorin Suppresses Bone Metastasis in a Breast Cancer Cell Line.

Published in:

Oncology, 2009, v. 77, n. 2, p. 92, doi. 10.1159/000228253

By:

Araki, Kentaro;
Wakabayashi, Hiroki;
Shintani, Ken;
Morikawa, Joji;
Matsumine, Akihiko;
Kusuzaki, Katsuyuki;
Sudo, Akihiro;
Uchida, Atsumasa

Publication type:

Article

Clinical Characteristics and Outcomes of Lung Cancer with Pulmonary Embolism.

Published in:

Oncology, 2009, v. 77, n. 2, p. 100, doi. 10.1159/000229503

By:

Yu-Min Chuang;
Chong-Jen Yu

Publication type:

Article

Pegfilgrastim Administered on the Same Day with Dose-Dense Adjuvant Chemotherapy for Breast Cancer Is Associated with a Higher Incidence of Febrile Neutropenia as Compared to Conventional Growth Factor Support: Matched Case-Control Study of the Hellenic Cooperative Oncology Group

Published in:

Oncology, 2009, v. 77, n. 2, p. 107, doi. 10.1159/000229504

By:

Skarlos, Dimosthenis V.;
Timotheadou, Eleni;
Galani, Eleni;
Samantas, Epaminondas;
Grimani, Irene;
Lianos, Evangelos;
Aravantinos, Gerasimos;
Xanthakis, Ioannis;
Pentheroudakis, George;
Pectasides, Dimitrios;
Fountzilas, George

Publication type:

Article

Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer.

Published in:

Oncology, 2009, v. 77, n. 2, p. 113, doi. 10.1159/000229787

By:

Sobrero, Alberto;
Ackland, Stephen;
Clarke, Stephen;
Perez-Carrión, Ramón;
Chiara, Silvana;
Gapski, John;
Mainwaring, Paul;
Langer, Bernd;
Young, Scott

Publication type:

Article

Clinical Predictors of Severe Cetuximab-Induced Rash: Observations from 933 Patients Enrolled in North Central Cancer Treatment Group Study N0147.

Published in:

Oncology, 2009, v. 77, n. 2, p. 120, doi. 10.1159/000229751

By:

Jatoi, Aminah;
Green, Erin M.;
Rowland Jr., Kendrith M.;
Sargent, Daniel J.;
Alberts, Steven R.

Publication type:

Article

Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab – an Antibody against Epidermal Growth Factor Receptor: Systemic Review and Meta-Analysis.

Published in:

Oncology, 2009, v. 77, n. 2, p. 124, doi. 10.1159/000229752

By:

Xiao Su;
Lacouture, Mario E.;
Yuxia Jia;
Shenhong Wu

Publication type:

Article

Good Response to Paclitaxel Predicts High Rates of Pathologic Complete Response for Breast Cancer Patients Treated Preoperatively with Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide.

Published in:

Oncology, 2009, v. 77, n. 2, p. 134, doi. 10.1159/000229753

By:

Seung Jin Kim;
Taguchi, Tetsuya;
Shimazu, Kenzo;
Tanji, Yoshio;
Tamaki, Yasuhiro;
Noguchi, Shinzaburo

Publication type:

Article

Limited Value of CA 19-9 in Predicting Early Treatment Failure in Patients with Advanced Pancreatic Cancer.

Published in:

Oncology, 2009, v. 77, n. 2, p. 140, doi. 10.1159/000229754

By:

Vormittag, Laurenz;
Gleiss, Andreas;
Scheithauer, Werner;
Lang, Fritz;
Laengle, Friedrich;
Kornek, Gabriela V.

Publication type:

Article